| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.800 | limited | 0.955 | 0 | 4 | 2009 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.800 | moderate | 0.955 | 0 | 3 | 1989 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.939 | 0 | 7 | 1987 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.961 | 0 | 27 | 1986 | 2020 | ||||||||
|
CREB binding protein | 0.428 | 0.808 | 1.00 |
|
disease | 0.600 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
splicing factor 3b subunit 1 | 0.511 | 0.731 | 1.00 |
|
disease | 0.500 | None | 1.000 | 0 | 6 | 2000 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.500 | None | 0.833 | 0 | 8 | 1987 | 2016 | ||||||||
|
colony stimulating factor 3 receptor | 0.550 | 0.692 | 1.5E-10 |
|
disease | 0.500 | None | 0.980 | 0 | 1 | 1995 | 2019 | ||||||||
|
nucleoporin 214 | 0.638 | 0.385 | 5.5E-02 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1999 | 2019 | ||||||||
|
MLLT10 histone lysine methyltransferase DOT1L cofactor | 0.551 | 0.462 | 1.00 |
|
disease | 0.500 | None | 0.958 | 0 | 0 | 1995 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
disease | 0.500 | None | 0.972 | 0 | 1 | 2000 | 2020 | ||||||||
|
Cbl proto-oncogene | 0.527 | 0.769 | 6.1E-04 |
|
disease | 0.500 | None | 1.000 | 0 | 10 | 2003 | 2019 | ||||||||
|
myeloid leukemia factor 1 | 0.666 | 0.385 | 4.4E-09 |
|
disease | 0.500 | None | 1.000 | 0 | 0 | 1996 | 2019 | ||||||||
|
phosphatidylinositol binding clathrin assembly protein | 0.592 | 0.538 | 1.00 |
|
disease | 0.490 | None | 1.000 | 0 | 0 | 2000 | 2012 | ||||||||
|
U2 small nuclear RNA auxiliary factor 1 | 0.604 | 0.577 | 0.99 |
|
disease | 0.470 | None | 1.000 | 0 | 2 | 2011 | 2019 | ||||||||
|
Janus kinase 1 | 0.474 | 0.769 | 1.00 |
|
disease | 0.430 | None | 1.000 | 0 | 6 | 2008 | 2018 | ||||||||
|
cysteine rich hydrophobic domain 2 | 0.769 | 0.231 | 0.54 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 1999 | 1999 | ||||||||
|
LIM domain containing preferred translocation partner in lipoma | 0.543 | 0.769 | 7.2E-03 |
|
disease | 0.410 | None | 1.000 | 0 | 0 | 2001 | 2001 | ||||||||
|
SH3 domain containing GRB2 like 1, endophilin A2 | 0.686 | 0.346 | 1.2E-02 |
|
disease | 0.400 | None | 0 | 0 | |||||||||||
|
protein tyrosine phosphatase receptor type T | 0.636 | 0.538 | 1.00 |
|
disease | 0.400 | None | 1.000 | 0 | 22 | 2017 | 2017 | ||||||||
|
interferon regulatory factor 1 | 0.468 | 0.769 | 0.99 |
|
disease | 0.380 | limited | 0.875 | 0 | 0 | 1993 | 2011 | ||||||||
|
BCL6 corepressor | 0.471 | 0.808 | 1.00 |
|
disease | 0.370 | None | 1.000 | 0 | 0 | 2011 | 2019 | ||||||||
|
E1A binding protein p300 | 0.459 | 0.846 | 1.00 |
|
disease | 0.360 | None | 1.000 | 0 | 0 | 1997 | 2013 | ||||||||
|
Rho GTPase activating protein 26 | 0.656 | 0.500 | 1.00 |
|
disease | 0.340 | None | 0.750 | 0 | 0 | 2006 | 2014 | ||||||||
|
cut like homeobox 1 | 0.465 | 0.846 | 1.00 |
|
disease | 0.330 | None | 0.667 | 0 | 0 | 1993 | 2019 |